Share Name Share Symbol Market Type Share ISIN Share Description
GlaxoSmithKline LSE:GSK London Ordinary Share GB0009252882 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +7.00p +0.43% 1,639.50p 1,641.50p 1,642.00p 1,642.00p 1,619.00p 1,631.50p 6,441,292.00 16:35:19
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 27,889.0 1,939.0 18.8 87.2 80,505.91

GlaxoSmithKline Share Discussion Threads

Showing 13901 to 13925 of 13925 messages
Chat Pages: 557  556  555  554  553  552  551  550  549  548  547  546  Older
DateSubjectAuthorDiscuss
24/2/2017
16:34
Strong close!
ny boy
24/2/2017
15:22
Quickly bought back!.
essentialinvestor
24/2/2017
15:20
Nice little bear trap to 1620p earlier!
ny boy
24/2/2017
13:22
Bullish article on GSk... Skim read it myself...but am sure Minerve might want to get their teeth into the financials GlaxoSmithKline's Valuation Is Compelling hTTp://seekingalpha.com/article/4048949-glaxosmithklines-valuation-compelling?app=1&auth_param=mhf3:1cau9o4:d348fd9d7a584dafb1156e8fe8c753da&uprof=44
fangorn2
24/2/2017
08:44
Creeping up a bit after the divi dive, which was expected and in line, on its best behavior, onwards to 1715p this quarter
ny boy
24/2/2017
07:55
Onwards to the next good news (and there's always the dividends) ..... ;0)
tradermichael
24/2/2017
07:54
I'd rather this news wasn't released on ex div day .... GlaxoSmithKline plc (LSE/NYSE:GSK) and Innoviva, Inc. (NASDAQ: INVA) today announced positive headline results from a non-inferiority lung function study, which demonstrated that patients with well-controlled asthma were able to switch to the once-daily Relvar(R) Ellipta(R) (fluticasone furoate/vilanterol, FF/VI) 100/25, an inhaled corticosteroid (ICS)/long-acting beta(2) agonist (LABA) combination, from the twice-daily Seretide(R) Accuhaler(R) (fluticasone propionate /salmeterol, FP/SAL) 250/50, without compromising their lung function.
tradermichael
23/2/2017
14:12
Yup, Buy & tuck away for me as well... Tempted to nibble some Astra Zeneca,Shire and Pfizer for drug expsoure.And a punt with some GW Pharms GlaxoSmithKline hails success in asthma medication trial hTTp://sharecast.com/news/glaxosmithkline-hails-success-in-asthma-medication-trial/25590875.html
fangorn2
23/2/2017
08:42
Aye, buyers are keen to get in by the looks of things, nice long term hold for me and divi collections.
ny boy
23/2/2017
07:38
The rise in share price from mid-January through February is real and realistic - not simply factoring in the dividend. Therefore, I do not expect any shrinking of the price by 23p to last for very long........ ;0)
tradermichael
22/2/2017
16:12
Divi is 23p.
woodhawk
22/2/2017
15:50
Ex divi tomorrow. What's the drop 20/25p?
ny boy
22/2/2017
14:01
Apologies. I've corrected it.
bracke
22/2/2017
13:56
I told you not to mention the wor (d)!!! :)
toffeeman
22/2/2017
13:31
Toffee Hmmm..... you may get away with it but I wouldn't discount a warning post from the anti-s brigade.
bracke
22/2/2017
13:02
Hi Bracke - yep - I know - but I didn't use the word just the start of it :)
toffeeman
22/2/2017
11:00
Toffee You are taking a chance using the 's' word it usually brings vitriolic posts threatening all sorts of dastardly deeds. tim Thank you.
bracke
22/2/2017
09:40
Trying to break higher, some mini resistance around 1650p
ny boy
21/2/2017
19:25
Nice chart bracke.
tim 3
21/2/2017
18:50
I bought at 1405 and plan to keep these - but I may take out a small s at 1700 as a wee hedge.
toffeeman
21/2/2017
17:30
Well it's going up on this leg, 1715p will be difficult to get through, so could retrace to around 1645p imho but I don't really sell at resistance, just hold and add more on any retrace.
ny boy
21/2/2017
17:21
Toffee Gold star for you. maurillac missed 'sideways'. Worth keeping an eye on the price action if you are thinking of a, I'll say it quietly, short.
bracke
21/2/2017
16:49
Nah it may go up or down or sideways :)
toffeeman
21/2/2017
15:07
so it could go up or down, or up, down and up again ;) m
maurillac
21/2/2017
12:46
Having reached the Median Line (middle green) it's decision time. Best option is 'zoom' through and keep going. Second best is move above ML then drop back for a successful retest. Third best is as second best but test fails to hold. Equal third, fails to break above ML and simply retraces. I suppose I should mention the possibility that the share price simply tracks up along the ML. GSK DAILY
bracke
Chat Pages: 557  556  555  554  553  552  551  550  549  548  547  546  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:35 V: D:20170226 17:13:52